Summary of Package Insert 1
|
|
- Claud Stewart
- 6 years ago
- Views:
Transcription
1 Summry of Pckge Insert 1 For Sttes with Non-Published Policies Indictions Non-infected prtil nd full-thickness skin ulcers due to VSU 2 of greter thn 1 month durtion nd which hve not dequtely responded to conventionl ulcer therpy. Full-thickness neuropthic DFU 3 of greter thn 3 weeks durtion which hve not dequtely responded to conventionl ulcer therpy nd which extend through the dermis but without tendon, muscle, cpsule or bone exposure. Limittions The sfety nd effectiveness of pligrf hve not been estblished for ptients receiving greter thn 5 device pplictions. oding PT/HPS 1,4 Q4101: pligrf, per squre centimeter For Plmetto G, J modifier must be billed in conjunction with Q4101 long with JW modifier for wstge ppliction odes for Leg 15271: ppliction of skin substitute grft to trunk, rms, legs, totl wound surfce re up to 100 sq cm; first 25 sq cm or less wound surfce re 15272: ppliction of skin substitute grft to trunk, rms, legs, totl wound surfce re up to 100 sq cm; ech dditionl 25 sq cm wound surfce re, or prt thereof (List seprtely in ddition to code for primry procedure) 15273: ppliction of skin substitute grft to trunk, rms, legs, totl wound surfce re greter thn or equl to 100 sq cm; first 100 sq cm wound surfce re 15274: ppliction of skin substitute grft to trunk, rms, legs, totl wound surfce re greter thn or equl to 100 sq cm; ech dditionl 100 sq cm wound surfce re, or prt therof (List seprtely in ddition to code for primry procedure) ppliction odes for Foot 15275: ppliction of skin substitute grft to fce, sclp, eyelids, mouth, neck, ers, orbits, genitli, hnds, feet, nd/or multiple digits, totl wound surfce re up to 100 sq cm; first 25 sq cm or less wound surfce re 15276: ppliction of skin substitute grft to fce, sclp, eyelids, mouth, neck, ers, orbits, genitli, hnds, feet, nd/or multiple digits, totl wound surfce re up to 100 sq cm; ech dditionl 25 sq cm wound surfce re, or prt thereof (List seprtely in ddition to code for primry procedure) 15277: ppliction of skin substitute grft to fce, sclp, eyelids, mouth, neck, ers, orbits, genitli, hnds, feet, nd/or multiple digits, totl wound surfce re greter thn or equl to 100 sq cm; first 100 sq cm wound surfce re 15278: ppliction of skin substitute grft to fce, sclp, eyelids, mouth, neck, ers, orbits, genitli, hnds, feet, nd/or multiple digits, totl wound surfce re greter thn or equl to 100 sq cm; ech dditionl 100 sq cm wound surfce re, or prt therof (List seprtely in ddition to code for primry procedure) 1 This document is for informtionl purposes only. Use of this informtion does not gurntee coverge or pyment for these services by Medicre or other pyors. Physicins nd other providers should use independent judgment when selecting codes tht most ppropritely describe the services provided to ptient. Physicins nd hospitls re solely responsible for complince with Medicre nd other pyors lws, rules, nd requirements. 2 VSU = Venous Stsis Ulcer. 3 DFU = Dibetic Foot Ulcer. 4 PT mericn Medicl ssocition. ll Rights Reserved HEL.2.DY ( ) pligrf is registered trdemrk of Novrtis 2012 Orgnogenesis, Inc.
2 nytown Hospitl 123 Medicl Drive nytown, NJ PT. 4 TYPE NTL # HI OF ILL b. MED. RE. # 5 FED. T NO. 6 STTEMENT OVERS PERIOD FROM THROUGH 8 PTIENT NME 9 PTIENT DDRESS b b c d 10 IRTHDTE 11 SE DMISSION ONDITION ODES 12 DTE 13 HR 14 TYPE 15 SR 16 DHR 29 DT STT STTE F 2012 No Forml Policy PI pligrf Smple U-04 lim Form Mple venue nytown NJ OURRENE 32 OURRENE 33 OURRENE 34 OURRENE 35 OURRENE SPN 36 OURRENE SPN 37 ODE DTE ODE DTE ODE DTE ODE DTE ODE FROM THROUGH ODE FROM THROUGH e b ll dtes VLUE ODES 40 VLUE ODES 41 VLUE ODES should be in ODE MOUNT ODE MOUNT ODE MOUNT eight digit Jne Smith formt. 111 Mple venue b nytown, NJ c d b REV. D. 43 DESRIPTION 44 HPS / RTE / HIPPS ODE 45 SERV. DTE 46 SERV. UNITS 47 TOTL HRGES 48 NON-OVERED HRGES pligrf Q ppliction, first 25 sq cm ppliction, ech dditionl 25 sq cm Enter pproprite revenue codes for ll services provided. Revenue code 636 should be used when billing for pligrf nd should be used bsed on the size of the wound. For exmple, LEG wound mesuring 30 sq cm, would be billed using (first 25 sq cm or less) nd (dditionl 25 sq cm or prt thereof). pligrf is supplied in 44 units PGE OF RETION DTE TOTLS PYER NME Medicre 51 HELTH PLN ID REL. INFO 53 SG. 54 PRIOR PYMENTS 55 EST. MOUNT DUE 56 NPI EN. 57 OTHER PRV ID 58 INSURED S NME 59 P. REL 60 INSURED S UNIQUE ID 61 GROUP NME 62 INSURNE GROUP NO. 63 TRETMENT UTHORIZTION ODES 64 DOUMENT ONTROL NUMER 65 EMPLOYER NME 66 D xxx.xx 67 Plese refer to odes ommonly Used when illing for pligrf forpproprite ID-9-M dignosis D E F G H codes nd your specific pyer s requirements. I J K L M N O P Q 69 DMIT 70 PTIENT 71 PPS D RESON D b c ODE EI b c 74 PRINIPL PROEDURE. OTHER PROEDURE b. OTHER PROEDURE 75 ODE DTE ODE DTE ODE DTE 76 TTENDING NPI QUL LST FIRST c. OTHER PROEDURE d. OTHER PROEDURE e. OTHER PROEDURE ODE DTE ODE DTE ODE DTE 77 OPERTING NPI QUL LST FIRST 80 REMRKS OTHER NPI QUL b LST FIRST 68 c 79 OTHER NPI QUL U-04 MS-1450 PPROVED OM NO d LST FIRST Ntionl Uniform NU illing ommittee THE ERTIFITIONS ON THE REVERSE PPLY TO THIS ILL ND RE MDE PRT HEREOF.
3 2012 No Forml Policy PI pligrf Smple MS-1500 lim Form Physicin Services in n Outptient Setting ny Street 123 ny Street NYTOWN NJ NYTOWN NJ (973) SIGNTURE ON FILE xxx xx xxx xx Plese refer to odes ommonly Used when illing for pligrf for pproprite ID-9-M dignosis codes nd your specific pyer s requirements nd should be used bsed on the size of the wound. For exmple, LEG wound mesuring 30 sq cm, would be billed using (first 25 sq cm or less) nd (dditionl 25 sq cm or prt thereof)
4 2012 No Forml Policy PI pligrf Smple MS-1500 lim Form Physicin Services in n Office Setting ny Street 123 ny Street NYTOWN NJ NYTOWN NJ (973) SIGNTURE ON FILE xxx xx xxx xx Plese refer to odes ommonly Used when illing for pligrf for pproprite ID-9-M dignosis codes nd your specific pyer s requirements Q pligrf is supplied in 44 units nd should be used bsed on the size of the wound. For exmple, LEG wound mesuring 30 sq cm, would be billed using (first 25 sq cm or less) nd (dditionl 25 sq cm or prt thereof)
5 Model Documenttion Form for No Forml Policy / Summry of Pckge Insert Pretretment: 1. Durtion of ulcer (DFU: 3 weeks, VSU: greter thn 1 month) weeks 2. Document filure to respond to conservtive mesures ( filed response is defined s n ulcer tht hs incresed in size or depth nd no indiction tht improvement is likely e.g., epithelil in growth nd progression towrds closure) 3. Document mesurement of the ulcer t bseline, following cesstion of conservtive mngement. 4. Describe dequte tretment of the underlying disese process contributing to the ulcer 5. Dignosis of ptient VSU: 454.0, 454.1, 454.2, , , , , DFU: , , , , , , , , , , , , , Document tht wound is free of infection, redness, dringe, underlying osteomyelitis, surrounding cellulitis, tunnels nd trcts, eschr or ny necrotic mteril 7. For DFU, document current Hb1 reding (Hb1 should not exceed 12%) 8. Document dequte rteril blood supply s evidenced by n I of 0.65 or greter ontinued on next pge > This document is for informtionl purposes only. Use of this informtion does not gurntee coverge or pyment for these services by Medicre or other pyors. LDs re updted by Medicre nd Medicre contrctors on regulr bsis. Physicins nd other providers should regulrly refer to the pplicble Medicre locl coverge determintions (LDs) for complete informtion on medicl necessity documenttion requirements. Physicins, providers nd hospitls re solely responsible for complince with Medicre nd other pyors lws, rules, nd requirements. pligrf is registered trdemrk of Novrtis 2010 Orgnogenesis, Inc.
6 Tretment: 9. Document mesurement of ulcer (width nd length or circumference nd depth) immeditely prior to ppliction of pligrf sq cm 10. Document whether this is n initil ppliction of pligrf or reppliction. (pligrf is limited to 5 pplictions per ulcer) 11. For pligrf repplictions, document tht pplictions hve been successful (e.g. decrese in size or depth, increse in grnultion tissue) 12. Document the wound dressing chnges nd the stndrd conservtive mesures ccompnying the wound tretment with pligrf 13. Document how the wound site ws prepred, nd how pligrf ws fixted on the wound This document is for informtionl purposes only. Use of this informtion does not gurntee coverge or pyment for these services by Medicre or other pyors. LDs re updted by Medicre nd Medicre contrctors on regulr bsis. Physicins nd other providers should regulrly refer to the pplicble Medicre locl coverge determintions (LDs) for complete informtion on medicl necessity documenttion requirements. Physicins, providers nd hospitls re solely responsible for complince with Medicre nd other pyors lws, rules, nd requirements. pligrf is registered trdemrk of Novrtis 2010 Orgnogenesis, Inc.
7 ID-9 M odes commonly used when billing for pligrf Vricose veins of lower extremities, with ulcer Vricose veins of lower extremities, with inflmmtion Vricose veins of lower extremities, with ulcer nd inflmmtion Postphlebitic syndrome with ulcer Postphlebitic syndrome with ulcer nd inflmmtion hronic venous hypertension with ulcer hronic venous hypertension with ulcer nd inflmmtion Other specified disorders of circultory system, venous (peripherl) insufficiency, unspecified Ulcer of lower limb, unspecified Ulcer of thigh Ulcer of clf Ulcer of nkle Ulcer of heel nd midfoot (Plntr surfce of midfoot) Ulcer of other prt of foot (Toes) Ulcer of other prt of lower limb hronic ulcer of other specified sites Secondry dibetes mellitus without mention of compliction, not stted s uncontrolled, Secondry dibetes mellitus without mention of compliction, uncontrolled Secondry dibetes mellitus with ketocidosis, not stted s uncontrolled, Secondry dibetes mellitus with ketocidosis, uncontrolled Secondry dibetes mellitus with hyperosmolrity, not stted s uncontrolled, Secondry dibetes mellitus with hyperosmolrity, uncontrolled Secondry dibetes mellitus with other com, not stted s uncontrolled, Secondry dibetes mellitus with other com, uncontrolled ontinued on next pge > pligrf is registered trdemrk of Novrtis 2010 Orgnogenesis, Inc.
8 Secondry dibetes mellitus with renl mnifesttions, not stted s uncontrolled, Secondry dibetes mellitus with renl mnifesttions, uncontrolled Secondry dibetes mellitus with ophthlmic mnifesttions, not stted s uncontrolled, Secondry dibetes mellitus with ophthlmic mnifesttions, uncontrolled Secondry dibetes mellitus with neurologicl mnifesttions, not stted s uncontrolled, Secondry dibetes mellitus with neurologicl mnifesttions, uncontrolled Secondry dibetes mellitus with peripherl circultory disorders, not stted s uncontrolled, Secondry dibetes mellitus with peripherl circultory disorders, uncontrolled Secondry dibetes mellitus with other specified mnifesttions, not stted s uncontrolled, Secondry dibetes mellitus with other specified mnifesttions, uncontrolled Secondry dibetes mellitus with unspecified compliction, not stted s uncontrolled, Secondry dibetes mellitus with unspecified compliction, uncontrolled Dibetes With Neurologicl Mnifesttions, Type II Or Unspecified Type, not stted s uncontrolled Dibetes With Neurologicl Mnifesttions, Type I (Juvenile Type), not stted s uncontrolled Dibetes With Neurologicl Mnifesttions, Type II Or Unspecified Type, uncontrolled Dibetes With Neurologicl Mnifesttions, Type I (Juvenile Type), uncontrolled Dibetes With Peripherl ircultory Disorders, Type II Or Unspecified type, not stted s uncontrolled Dibetes With Peripherl ircultory Disorders, Type I (Juvenile Type), not stted s uncontrolled Dibetes With Peripherl ircultory Disorders, Type II Or Unspecified type, uncontrolled Dibetes With Peripherl ircultory Disorders, Type I (Juvenile Type), uncontrolled Dibetes with other specified mnifesttions, type II type, not stted s uncontrolled Dibetes with other specified mnifesttions, type I, not stted s uncontrolled Dibetes with other specified mnifesttions, type II type, uncontrolled Dibetes with other specified mnifesttions, type I, uncontrolled 1 This brief summry is provided for considertion only. ll codes provided herein re for informtion purposes only nd shll not be construed s sttement, promise, or gurntee tht these codes re ccurte or reimbursement will be received. oding requirements re subject to chnge t ny time, therefore check with your locl pyer regulrly to verify prior uthoriztion requirements. pligrf is registered trdemrk of Novrtis 2010 Orgnogenesis, Inc.
Billing and Coding Guide. Hospital Outpatient Department
illing nd oding Guide Hospitl Outptient Deprtment overge, coding, nd pyment in the hospitl outptient deprtment ONPTTRO (ptisirn) received US Food nd Drug dministrtion (FD) pprovl on 10 ug 2018, nd is indicted
More informationSAMPLE CLAIM FORMS FOR SPINRAZA
SMPLE LIM FORMS FOR SPINRZ Please see accompanying full Prescribing Information for additional Important Safety Information. SMPLE MS-1450/U-04 LIM FORM FOR OUTPTIENT HOSPITL-SED FILITIES a Field 46: Enter
More informationSummary of Package Insert 1 for PuraPly Wound Matrix
Summary of Package Insert 1 for PuraPly Wound Matrix For NGS Indications Indicated for the management of wounds including: Partial and full-thickness wounds Venous ulcers Diabetic ulcers Drainage wounds
More informationSupplementary Online Content
Supplementry Online Content Zulmn DM, Pl Chee C, Ezeji-Okoye SC, et l. Effect of n intensive outptient progrm to ugment primry cre for high-need Veterns Affirs ptients: rndomized clinicl tril. JAMA Intern
More informationSummary of Package Insert 1 for PuraPly Antimicrobial Wound Matrix
Summary of Package Insert 1 for PuraPly Antimicrobial Wound Matrix For States with Non-Published Policies-Novitas Indications Indicated for the management of wounds as an effective barrier to resist microbial
More informationCahaba Medicare Policy Primer 1,2 for Apligraf
Cahaba Medicare Policy Primer 1,2 for Apligraf MAC A: AL, GA & TN MAC B: AL, GA, & TN LCD# 31428 Indications Applied to partial- or full-thickness ulcers of the lower extremities (see individual product
More informationPalmetto Medicare Policy Primer
Palmetto Medicare Policy Primer Medicare Jurisdiction (JM) NC, SC, WV & VA Application of Skin Substitutes LCD #L36466 Indications Presence of neuropathic diabetic foot ulcer(s) having failed to respond
More informationOregon Individual and Family Plans OREGON APPLICATION AND STANDARD HEALTH STATEMENT
B CDE Regence BlueCross BlueShield of Oregon Oregon Individul nd Fmily Plns Blue Selections Premier Blue Selections Plus Blue Selections Bsic Regence HS Helthpln nd Individul Dentcre OREGON PPLICTION ND
More informationNovitas Medicare Policy Primer
Novitas Medicare Policy Primer Medicare Jurisdiction (JL and JH) AR, CO, LA, MS, NM, OK, TX, DC, DE, MD, NJ, & PA Counties of Arlington and Fairfax in Virginia and the city of Alexandria in Virginia Application
More informationBright Futures Medical Screening Reference Table 2 to 5 Day (First Week) Visit
Bright Futures Medicl Reference Tle 2 to 5 Dy (First Week) Visit Universl Action Metolic nd Verify documenttion of neworn metolic screening results, pproprite rescreening, nd needed follow-up. Document
More informationWPS Medicare Policy Primer
WPS Medicare Policy Primer Medicare Jurisdiction (J5 & J8) NE, KS, IA, MO, IN, & MI Retired skin substitute LCD 3/2016 Indications Apligraf Non-infected partial and full-thickness skin ulcers due to VSU
More informationCODING AND REIMBURSEMENT GUIDE
ODING ND REIMURSEMENT GUIDE Dignosis, ND, nd ID-10-M 1 illing codes for ogultion Fctor IX (Recominnt), lumin Fusion Protein THE FIRST ND ONLY rfix THERPY THT DELIVERS HIGH-LEVEL PROTETION WITH UP TO 14-DY
More informationCGS Medicare Policy Primer
CGS Medicare Policy Primer Medicare Jurisdiction (J15) OH & KY Wound Application of Cellular and/or Tissue Based Products (CTPs) Lower Extremities #L36690 Indications Application of a CTP graft for lower
More informationClinical Study Report Synopsis Drug Substance Naloxegol Study Code D3820C00018 Edition Number 1 Date 01 February 2013 EudraCT Number
EudrCT Number 2012-001531-31 A Phse I, Rndomised, Open-lbel, 3-wy Cross-over Study in Helthy Volunteers to Demonstrte the Bioequivlence of the Nloxegol 25 mg Commercil nd Phse III Formultions nd to Assess
More informationPNEUMOVAX 23 is recommended by the CDC for all your appropriate adult patients at increased risk for pneumococcal disease 1,2 :
PNEUMOVAX 23 is recommended y the CDC for ll your pproprite dult ptients t incresed risk for pneumococcl disese 1,2 : Adults ged
More informationUsing Paclobutrazol to Suppress Inflorescence Height of Potted Phalaenopsis Orchids
Using Pcloutrzol to Suppress Inflorescence Height of Potted Phlenopsis Orchids A REPORT SUBMITTED TO FINE AMERICAS Linsey Newton nd Erik Runkle Deprtment of Horticulture Spring 28 Using Pcloutrzol to Suppress
More informationImpact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting
Impct of Phrmcist Intervention on Dibetes Ptients in n Ambultory Setting Julie Stding, PhrmD, CDE, Jmie Herrmnn, PhrmD, Ryn Wlters, MS, Chris Destche, PhrmD, nd Aln Chock, PhrmD Dibetes is the seventh-leding
More informationFirst Coast Service Options (FCSO) Medicare Policy Primer
First Coast Service Options (FCSO) Medicare Policy Primer Medicare Jurisdiction (JN) Florida, Puerto Rico and U.S. Virgin Islands Application of Skin Substitute Grafts for the treatment of DFU and VLU
More informationPatient Identification. a Yes. a No. Patient: First. Last. Address: Street. Apt. State. City. Zip. Date of Birth: Weight: Age: Race:
Ptient Medicl History Ptient Identifiction Hve you been ptient heree before? Ptient: First MI Lst Miling Address: Street Apt City Stte Zip Home Phone Cell/Alternte Phone Age: Height: Weight: Dte of Birth:
More informationCommunity. Profile Powell County. Public Health and Safety Division
Community Helth Profile 2015 Powell County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationCommunity. Profile Big Horn County. Public Health and Safety Division
Community Helth Profile 2015 Big Horn County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Yellowstone County. Public Health and Safety Division
Community Helth Profile 2015 Yellowstone County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Lewis & Clark County. Public Health and Safety Division
Community Helth Profile 2015 Lewis & Clrk County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Missoula County. Public Health and Safety Division
Community Helth Profile 2015 Missoul County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationCommunity. Profile Anaconda- Deer Lodge County. Public Health and Safety Division
Community Helth Profile 2015 Ancond- Deer Lodge County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12
More informationInvasive Pneumococcal Disease Quarterly Report July September 2018
Invsive Pneumococcl Disese Qurterly Report July Septemer Introduction Since 17 Octoer 2008, invsive pneumococcl disese (IPD) hs een notifile to the locl Medicl Officer of Helth under the Helth Act 1956.
More informationComputer-Aided Learning in Insulin Pump Training
Journl of Dibetes Science nd Technology Volume 4, Issue 4, July 2010 Dibetes Technology Society TECHNOLOGY REPORTS Computer-Aided Lerning in Insulin Pump Trining Sergey V., M.Sc., 1 nd Chrles J. George,
More informationXII. HIV/AIDS. Knowledge about HIV Transmission and Misconceptions about HIV
XII. HIV/AIDS Knowledge bout HIV Trnsmission nd Misconceptions bout HIV One of the most importnt prerequisites for reducing the rte of HIV infection is ccurte knowledge of how HIV is trnsmitted nd strtegies
More informationCoding for Wound Care
Coding for Wound Care ****IMPORTANT*** Disclaimer ***Information provided is to the best of our knowledge and as current as possible. ***Please verify all policy and reimbursement information with your
More informationInvasive Pneumococcal Disease Quarterly Report. July September 2017
Invsive Pneumococcl Disese Qurterly Report July September 2017 Prepred s prt of Ministry of Helth contrct for scientific services by Rebekh Roos Helen Heffernn October 2017 Acknowledgements This report
More informationSUSPECT ADVERSE REACTION REPORT
CIOMS FORM SUSPECT ADVERSE REACTION REPORT DE-BFARM-16390235 I. REACTION INFORMATION 1. PATIENT INITIALS 1. COUNTRY 2. DATE OF BIRTH 2. AGE 3. SEX 4-6 REACTION ONSET privcy (10000059): Abdominl discomfort
More informationCommunity. Profile Carter County. Public Health and Safety Division
Community Helth Profile 2015 Crter County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationPressure Ulcers ecourse: Module 2 Quiz II
Pressure Ulcers ecourse: Moule 2 Quiz II 1. Yellow or white tissue tht heres to the ulcer be in strings or thick clumps or is mucinous is:. Eschr b. Slough c. Grnultion tissue. Epithelil tissue 2. New
More informationSeasonal influenza vaccination programme country profile: Ireland
Sesonl influenz vccintion progrmme country profile: Irelnd 2012 13 Seson Bckground informtion Influenz immunistion policy nd generl fcts bout Irelnd Volume indices of GDP per cpit in 2011 nd 2013 (EU-
More informationTopical Oxygen Wound Therapy (MEDICAID)
Topical Oxygen Wound Therapy (MEDICAID) Last Review Date: September 8, 2017 Number: MG.MM.DM.15C8v2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or
More informationDiabetes affects 29 million Americans, imposing a substantial
CLINICAL Comprtive Effectiveness nd Costs of Insulin Pump Therpy for Dibetes Ronld T. Ackermnn, MD, MPH; Amish Wlli, MD, MS; Rymond Kng, MA; Andrew Cooper, MPH; Theodore A. Prospect, FSA, MAAA; Lewis G.
More informationSupplementary Online Content
Supplementry Online Content Rieckmnn N, Kronish IM, Shpiro PA, Whng W, Dvidson KW. Serotonin reuptke inhibitor use, depression, nd long-term outcomes fter n cute coronry : prospective cohort study. JAMA
More informationAssessment of Depression in Multiple Sclerosis. Validity of Including Somatic Items on the Beck Depression Inventory II
Assessment of Depression in Multiple Sclerosis Vlidity of Including Somtic Items on the Beck Depression Inventory II Peggy Crwford, PhD; Noh J. Webster, MA Signs nd symptoms of multiple sclerosis (MS)
More informationMETHOD 4010 SCREENING FOR PENTACHLOROPHENOL BY IMMUNOASSAY
METHOD 4010 SCREENING FOR PENTACHLOROPHENOL BY IMMUNOASSAY 1.0 SCOPE AND APPLICATION 1.1 Method 4010 is procedure for screening solids such s soils, sludges, nd queous medi such s wste wter nd lechtes
More information5 WAYS VCARE? What is GLAUCOMA. has earned the highest MEDICAID? Are you on. Are you at Risk? Viva Medicare Plus. to Avoid Hospital Readmissions
Enjoy Life! 5 WAYS to Avoid Hospitl Redmissions FOR THE THIRD YEAR IN A ROW, Viv Medicre Plus hs erned the highest MEDICARE STAR RATING GIVEN IN ALABAMA. GLAUCOMA Are you t Risk? Wht is VCARE? Are you
More informationUtilization of dental services in Southern China. Lo, ECM; Lin, HC; Wang, ZJ; Wong, MCM; Schwarz, E
Title Utiliztion of dentl services in Southern Chin Author(s) Lo, ECM; Lin, HC; Wng, ZJ; Wong, MCM; Schwrz, E Cittion Journl Of Dentl Reserch, 2001, v. 80 n. 5, p. 1471-1474 Issued Dte 2001 URL http://hdl.hndle.net/10722/53200
More informationBENIGN ulceration along the greater curvature of the pars media of the
BENIGN ULCERS OF THE GREATER CURVATURE OF THE STOMACH Report of Two Cses CHARLES H. BROWN, M.D. Deprtment of Gstroenterology nd ANTHONY D. INTRIERE, M.D.* BENIGN ulcertion long the greter curvture of the
More informationEffect on Glycemic, Blood Pressure, and Lipid Control according to Education Types
Originl Article http://dx.doi.org/10.4093/dmj.2011.35.6.580 pissn 2233-6079 eissn 2233-6087 D I A B E T E S & M E T A B O L I S M J O U R N A L Effect on Glycemic, Blood Pressure, nd Lipid Control ccording
More informationWelcome to our Practice
Welcome to our Prctice PATIENT INFORMATION: Mr. Mrs. Ms. Dr. First Nme_ Sex: Mle Femle Street Home. Referred By Dentist. Driver's Lic.# Employer. Birth Dte In cse of emergency, plese contct..cell.i..m.i..
More informationDermACELL AWM Comprehensive Reimbursement Resource Guide. Prepared by Musculoskeletal Clinical Regulatory Advisers, LLC. Version 01/2018.
2018 Comprehensive Reimbursement Resource Guide Prepared by Musculoskeletal Clinical Regulatory Advisers, LLC. Version 01/2018. DermACELL AWM Disclaimer: This information is for educational/informational
More informationVitamin D and Mushrooms: Enrichment With Pulsed UV Light. Michael Kalaras Department of Food Science The Pennsylvania State University
Vitmin D nd Mushrooms: Enrichment With Pulsed UV Light Michel Klrs Deprtment of Food Science The Pennsylvni Stte University Vitmin D Synthesis Source: http://vitmind.ucr.edu/imges/chem1.gif Vitmin D In
More informationOriginal Article. T Akter 1, N Islam 2, MA Hoque 3, S Khanam 4, HA khan 5, BK Saha 6. Abstract:
Fridpur Med. Coll. J. 214;9(2):61-67 Originl Article Nebuliztion by Isotonic Mgnesium Sulphte Solution with Provide Erly nd Better Response s Compred to Conventionl Approch ( Plus Norml Sline) in Acute
More informationWhangarei District Council Class 4 Gambling Venue Policy
Whngrei Distrit Counil Clss 4 Gmling Venue Poliy April 2013 Whngrei Distrit Counil Clss 4 Gmling Venue Poliy Tle of ontents Introdution... 3 1 Ojetives of the poliy in so fr s promoted y the Gmling At
More informationWHEN PRECISE PLACEMENT IS CRITICAL
WHEN PRECISE PLACEMENT IS CRITICAL Stent Positioning System Ostil Pro Stent Positioning System Ostil Pro Stent Positioning System Fcilittes More Accurte Stent Positioning in AO Lesions OSTIAL PRO Stent
More informationSafety and Tolerability of Subcutaneous Sarilumab and Intravenous Tocilizumab in Patients With RA
Sfety nd Tolerbility of Subcutneous Srilumb nd Intrvenous Tocilizumb in Ptients With RA Pul Emery, 1 Jun Rondon, 2 Anju Grg, 3 Hubert vn Hoogstrten, 3 Neil M.H. Grhm, 4 Ming Liu, 4 Nncy Liu, 3 Jnie Prrino,
More informationUrinary Tract Infection in Women
C H A P T E R 1 8 Urinry Trct Infection in Women Toms L. Griebling, MD Associte Professor & Vice Chir of Urology University of Knss Knss City, Knss Contents INTRODUCTION........................................589
More informationSurgical Preparation Codes for Skin Replacement Surgery** Hospital Outpatient/Ambulatory Surgical Center Setting
2018 National Medicare Reimbursement Rate Summary* for Integra Dermal Regeneration Template, & Office Settings Integra LifeSciences Corporation compiles this summary of Medicare payment rates to provide
More informationUrinary Tract Infection in Men
C H A P T E R 1 9 Urinry Trct Infection in Men Toms L. Griebling, MD Associte Professor & Vice Chir of Urology University of Knss Knss City, Knss Contents INTRODUCTION........................................623
More informationChronic obstructive pulmonary disease (COPD) is the third
METHODS Clims-Bsed Risk Model for First Severe COPD Excerbtion Richrd H. Stnford, PhrmD, MS; Arpit Ng, PhD, MBA, MS; Dougls W. Mpel, MD; Todd A. Lee, PhD; Richrd Rosiello, MD; Michel Schtz, MD; Frncis
More informationTarget: 10 mg/day within several days Schizophrenia in adolescents (2.1)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include ll the informtion needed to use ZYPREXA sfely nd effectively. See full prescribing informtion for ZYPREXA. ZYPREXA (olnzpine) Tblet
More informationThe Effects of Small Sized Rice Bowl on Carbohydrate Intake and Dietary Patterns in Women with Type 2 Diabetes
Originl Article doi: 10.4093/kdj.2010.34.3.166 pissn 1976-9180 eissn 2093-2650 The Effects of Smll Sized Rice Bowl on Crbohydrte Intke nd Dietry Ptterns in Women with Type 2 Dibetes Hee-Jung Ahn 1, *,
More informationClinical Policy: EpiFix Wound Treatment
Clinical Policy: Reference Number: PA.CP.MP.140 Effective Date: 03/18 Last Review Date: 04/18 Coding Implications Revision Log Description EpiFix (MiMedx Group) is dehydrated human amniotic tissue that
More informationAetna Health Management HMO Products SouthEast Region (Including Arkansas) Medical and Non-Medical Approvals and Denials from 01/01/2018 to 03/31/2018
Aetn Helth Mngement HMO Products SouthEst Region (Including Arknss) Medicl nd Non-Medicl Approvls nd Denils from 0/0/208 to 03/3/208 Code 5840 Inptient Medicl nd Non-Medicl Approvls nd Denils Top 0 Provider/Fcility
More informationThe Quality and Outcomes Framework (QOF) is a pay-for-performance
Effect of UK Py-for-Performnce Progrm on Ethnic Disprities in Dibetes Outcomes: Interrupted Time Series Anlysis Riydh Alshmsn, MSc John Tyu Lee, MSc Azeem Mjeed, MD Goplkrishnn Netuveli, PhD Christopher
More informationWound & Burn. Reimbursement & Coding Guide
Wound & Burn Reimbursement & Coding Guide Wound & Burn Reimbursement and Coding Guide MicroMatrix and Cytal devices facilitate the remodeling of functional, site-appropriate tissue. Comprised of ACell
More informationSYNOPSIS Final Abbreviated Clinical Study Report for Study CA ABBREVIATED REPORT
Finl Arevited Clinicl Study Report Nme of Sponsor/Compny: Bristol-Myers Squi Ipilimum Individul Study Tle Referring to the Dossier (For Ntionl Authority Use Only) Nme of Finished Product: Yervoy Nme of
More informationβ-hydroxybutirate Levels as a Determinant for The Success of Diabetic Ketoacidosis Management
ORIGINAL ARTICLE β-hydroxybutirte Levels s Determinnt for The Success of Dibetic Ketocidosis Mngement Ik Prsety Wijy*, Prdn Soewondo**, Djoko Widodo***, Aru W. Sudoyo**** ABSTRACT Aim: to obtin greter
More informationMultiple sclerosis (MS) affects approximately. Triaging Patients with Multiple Sclerosis in the Emergency Department. Room for Improvement
Systemtic Review of Tools for Anxiety in MS MS CARE DELIVERY: CHALLENGES AND INVATIONS Triging Ptients with Multiple Sclerosis in the Emergency Deprtment Room for Improvement Heshm Abboud, MD, PhD; Krin
More informationbuild Firm, sexy arms
w uild Firm, sexy rms Wnt toned, strong rms tht crown you pushup queen t oot cmp? Wnt to rock tnk top? These four moves re wht you need. Achieve Totl Arm Envy Mny women zero in on the show-off muscles,
More informationCLPNA Pressure Ulcers ecourse: Module 5.3 Quiz I page 1
CLPNA Pressure Ulcers ecourse: Module 5.3 Quiz I 1. Clensing is the process of clening nd sterilizing pressure ulcer wound. 2. How often should pressure ulcer wound nd surrounding skin be clensed?. Every
More informationInput from external experts and manufacturer on the 2 nd draft project plan Stool DNA testing for early detection of colorectal cancer
Input externl experts nd mnufcturer on the 2 nd drft project pln Stool DNA testing for erly detection of colorectl cncer (Project ID:OTJA10) All s nd uthor s replies on the 2nd drft project pln Stool DNA
More information8/1/2017. Correlating Radiomics Information with Clinical Outcomes for Lung SBRT. Disclosure. Acknowledgements
Correlting Rdiomics Informtion with Clinicl Outcomes for Lung SBRT Fng-Fng Yin, PhD Duke University Medicl Center AAPM 2017 Denver CO Disclosure This reserch is prtilly funded by reserch grnt from Vrin
More informationAetna Health Management HMO Products SouthEast Region (Including Arkansas) Medical and Non-Medical Approvals and Denials from 01/01/2017 to 03/31/2017
Aetn Helth Mngement HMO Products SouthEst Region (Including Arknss) Medicl nd Non-Medicl Approvls nd Denils from 01/01/2017 to 03/31/2017 Code Inptient Medicl nd Non-Medicl Approvls nd Denils Top 10 Provider/Fcility
More informationTrends in antihypertensive and lipidlowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
ORIGINAL ARTICLE Trends in ntihypertensive nd lipidlowering therpy in subjects with type II dibetes: clinicl effectiveness or clinicl discretion? MC Gulliford, J Chrlton nd R Ltinovic Deprtment of Public
More informationEfficacy of Sonidegib in Patients With Metastatic BCC (mbcc)
AAD 216 eposter 3368 Efficcy of Sonidegib in Ptients With Metsttic BCC (mbcc) Colin Morton, 1 Michel Migden, 2 Tingting Yi, 3 Mnish Mone, 3 Dlil Sellmi, 3 Reinhrd Dummer 4 1 Stirling Community Hospitl,
More informationThis is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled.
This is controlled document. The mster document is posted on the JRCO wesite nd ny print-off of this document will e clssed s uncontrolled. Reserchers nd their tems my print off this document for trining
More informationC reactive protein: an aid to assessment and
C rective protein: n id to ssessment nd monitoring of cute pncretitis J Clin Pthol 1984;37:27-211 AD MAYR,* MJ McMAHON,* MARGART BOWN,t H COOPRt From the *University Deprtment ofsurgery, Generl Infrmry,
More informationSummary. Effect evaluation of the Rehabilitation of Drug-Addicted Offenders Act (SOV)
Summry Effect evlution of the Rehbilittion of Drug-Addicted Offenders Act (SOV) The Rehbilittion of Drug-Addicted Offenders Act (SOV) ws lunched on April first 2001. This lw permitted the compulsory plcement
More informationphosphatase isoenzyme activity: estimation of
J Clin Pthol 1988;41:202-206 Quntittive method for determining serum lkline phosphtse isoenzyme ctivity: estimtion of intestinl component M J PEAKE, M PEJAKOVIC, G H WHITE From the Deprtment ofbiochemistry
More informationA Four-System Comparison of Patients With Chronic Illness: The Military Health System, Veterans Health Administration, Medicaid, and Commercial Plans
MILITARY MEDICINE, 174, 9:936, 2009 A Four-System Comprison of Ptients With Chronic Illness: The Militry Helth System, Veterns Helth Administrtion, Medicid, nd Commercil Plns Teres B. Gibson, PhD * ; Todd
More informationA survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project
Originl ppers A survey of tril fibrilltion in generl prctice: the West Birminghm Atril Fibrilltion Project GREGORY Y H LIP DANIEL J GOLDING MASOOD NAZIR D GARETH BEEVERS DAVID L CHILD R IAN FLETCHER SUMMARY
More informationAppendix J Environmental Justice Populations
Appendix J Environmentl Justice s [This pge intentionlly left blnk] Tble of Contents REFERENCES...J-2 Pge LIST OF TABLES Pge Tble J-1: Demogrphic Overview of Bruinsburg Site Project Are... J-3 Tble J-2:
More informationA cross-sectional and follow-up study of leukopenia in tuberculosis patients: prevalence, risk factors and impact of anti-tuberculosis
Originl Article A cross-sectionl nd follow-up study of leukopeni in tuberculosis ptients: prevlence, risk fctors nd impct of nti-tuberculosis tretment Fei-Shen Lin 1 *, Mei-Ying Wu 2 *, Wen-Jun Tu 3, Hong-Qiu
More informationIntroduction. These patients benefit less from conventional chemotherapy than patients identified as MMR proficient or microsatellite stable 3-5
Nivolumb + Ipilimumb Combintion in Ptients With DNA Mismtch Repir-Deficient/Microstellite Instbility-High Metsttic Colorectl Cncer: First Report of the Full Cohort From CheckMte-142 Abstrct 553 André T,
More informationReview TEACHING FOR GENERALIZATION & MAINTENANCE
Gols By the end of clss, you should be ble to: Explin wht generliztion is, why it is criticl for techers to know how to tech so tht it occurs, nd give n exmple of it from your own experience in the clssroom
More informationkey words: chronic obstructive pulmonary disease, beta agonists, Medicare, health care costs, health care utilization
reserch report Helth Cre Use nd Costs Among Medicre Ptients With Chronic Obstructive Pulmonry Disese Treted With Short-Acting Bet Agonists or Long-Acting Bet Agonists Flvi Ejzykowicz, PhD; 1 Vmsi K Bollu,
More informationOpioid Use and Survival at the End of Life: A Survey of a Hospice Population
532 Journl of Pin nd Symptom Mngement Vol. 32 No. 6 December 2006 NHPCO Originl Article Opioid Use nd Survivl t the End of Life: A Survey of Hospice Popultion Russell K. Portenoy, MD, Un Sibircev, BA,
More informationT.S. Kurki a, *,U.Häkkinen b, J. Lauharanta c,j.rämö d, M. Leijala c
Europen Journl of Crdio-thorcic Surgery 20 (2001) 1183 1187 www.elsevier.com/locte/ejcts Evlution of the reltionship between preopertive risk scores, postopertive nd totl length of stys nd hospitl costs
More informationTAKE CONTROL HIGH LEVEL
TAKE CONTROL TO A HIGH Clyton, 34 yers old, is pilot who hikes nd cmps in his spre time. Clyton lives with hemophili B. LEVEL Reinyn Rech for high fctor levels in hemophili B 1 Json, 8 yers old, spends
More informationFinite-Dimensional Linear Algebra Errata for the first printing
Finite-Dimensionl Liner Algebr Errt for the first printing Mrk S. Gockenbch Jnury 6, 011 The following corrections will be mde in the second printing of the text, expected in 011. Pge 41: Exercise 5: S
More informationCheckMate 153: Randomized Results of Continuous vs 1-Year Fixed-Duration Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer
CheckMte 53: Rndomized Results of Continuous vs -Yer Fixed-Durtion Nivolumb in Ptients With Advnced Non-Smll Cell Lung Cncer Abstrct 297O Spigel DR, McCleod M, Hussein MA, Wterhouse DM, Einhorn L, Horn
More informationORIGINAL ARTICLE. Diagnostic Signs of Accommodative Insufficiency. PILAR CACHO, OD, ÁNGEL GARCÍA, OD, FRANCISCO LARA, OD, and M A MAR SEGUÍ, OD
1040-5488/02/7909-0614/0 VOL. 79, NO. 9, PP. 614 620 OPTOMETRY AND VISION SCIENCE Copyright 2002 Americn Acdemy of Optometry ORIGINAL ARTICLE Dignostic Signs of Accommodtive Insufficiency PILAR CACHO,
More informationPatient Survival After Surgical Treatment of Rectal Cancer
Originl Article Ptient Survivl After Surgicl Tretment of Rectl Cncer Impct of Surgeon nd Hospitl Chrcteristics Dvid A. Etzioni, MD, MSHS 1,2 ; Toni M. Young-Fdok, MD, MS 1 ; Robert R. Cim, MD, MA 2,3 ;
More informationAgilent G6825AA MassHunter Pathways to PCDL Software Quick Start Guide
Agilent G6825AA MssHunter Pthwys to PCDL Softwre Quick Strt Guide Wht is Agilent Pthwys to PCDL? Fetures of Pthwys to PCDL Agilent MssHunter Pthwys to PCDL converter is stnd-lone softwre designed to fcilitte
More informationTHE 2017 GENENTECH ONCOLOGY TREND REPORT
THE 2017 GEETECH OCOLOGY TRED REPORT Perspectives From: Mnged Cre Orgniztions, Specilty Phrmcies, Oncologists, Prctice Mngers, nd Employers 9 th Edition THE 2017 GEETECH OCOLOGY TRED REPORT Editoril Bord
More informationEFFECTS OF INGREDIENT AND WHOLE DIET IRRADIATION ON NURSERY PIG PERFORMANCE
Swine Dy 21 EFFECTS OF INGREDIENT AND WHOLE DIET IRRADIATION ON NURSERY PIG PERFORMANCE J. M. DeRouchey, M. D. Tokch, J. L. Nelssen, R. D. Goodbnd, S. S. Dritz 1, J. C. Woodworth, M. J. Webster, B. W.
More informationof comorbid conditions, interventions Diagnosis and treatment, treatment reduction of risk factors for CVD to slow disease progression,
Tble 5.1. NKF Clssifiction of Chronic Kidney Disese nd Clinicl Fetures Stge Description GFR (ml/ min/1.73 m 2 ) U.S. Prevlence, b # Affected (%) Clinicl Fetures Action Pln c At incresed risk for CKD >60
More informationSoybean Hulls as an Alternative Feed for Horses
Animl Industry Report AS 650 ASL R1931 2004 Soyben Hulls s n Alterntive Feed for Horses Josie Booth Iow Stte University Howrd Tyler Iow Stte University Peggy Miller-Auwerd Iow Stte University Jenette Moore
More informationOriginal Article INTRODUCTION. Korean Diabetes J 2010;34: doi: /kdj pissn eissn
Originl Article doi: 1.493/kdj.21.34.6.34 pissn 1976-918 eissn 293-265 The Smll Rice Bowl-Bsed Mel Pln ws Effective t Reducing Dietry Energy Intke, Body Weight, nd Blood Glucose Levels in Koren Women with
More informationRising costs have led to a number of federal initiatives to
Implictions of DRG Clssifiction in Bundled yment Inititive for COD TRISHA M. AREKH, DO; SURYA. BHATT, MD; ANDREW O. WESTFALL, MS; JAMES M. WELLS, MD; DENAY KIRKATRICK, DN, AN-BC; ANAND S. IYER, MD; MICHAEL
More informationAnemia in pediatric hemodialysis patients: Results from the 2001 ESRD Clinical Performance Measures Project
Kidney Interntionl, Vol. 64 (2003), pp. 1120 1124 Anemi in peditric hemodilysis ptients: Results from the 2001 ESRD Clinicl Performnce Mesures Project DIANE L. FRANKENFIELD, ALICA M. NEU, BRADLEY A. WARADY,
More informationReducing the Risk. Logic Model
Reducing the Risk Logic Model ETR (Eduction, Trining nd Reserch) is nonprofit orgniztion committed to providing science-bsed innovtive solutions in helth nd eduction designed to chieve trnsformtive chnge
More informationPresented at the 75 th Annual Meeting of the American Academy of Dermatology, Orlando, FL, March 3-7, 2017 METHODS INTRODUCTION OBJECTIVE
Seven-Yer Interim Results from the ESPRIT 10-Yer Postmrketing Surveillnce Registry of Adlimumb for Moderte to Severe Psorisis Frncisco Kerdel, 1 Aln Menter, 2 Jshin J. Wu, 3 Mreike Bereswill, 4 Dilek Arikn,
More information